2 Ways Aurora Cannabis Is Shooting Itself in the Foot

Canada-based Aurora Cannabis (NASDAQ: ACB) has long been a favorite of investors, having made many of them millionaires in the past after it began selling medical cannabis in the first quarter of 2016 (Canada legalized medical cannabis in 2001). In just the two years between 2016 and 2018, Aurora’s share price shot up by 2,400%. The year 2020 was a dreadful one for the company, which repeatedly failed to live up to its promise of achieving positive earnings before interest, tax, depreciation, and amortization (EBITDA).

READ MORE: https://finance.yahoo.com/m/a11b4011-e230-3808-8ba4-794e05be9ed3/2-ways-aurora-cannabis-is.html?.tsrc=rss